Literature DB >> 25012035

[Cannabis smoking and lung cancer].

M Underner1, T Urban2, J Perriot3, I de Chazeron4, J-C Meurice5.   

Abstract

Cannabis is the most commonly smoked illicit substance in the world. It can be smoked alone in plant form (marijuana) but it is mainly smoked mixed with tobacco. The combined smoking of cannabis and tobacco is a common-place phenomenon in our society. However, its use is responsible for severe pulmonary consequences. The specific impact of smoking cannabis is difficult to assess precisely and to distinguish from the effect of tobacco. Marijuana smoke contains polycyclic aromatic hydrocarbons and carcinogens at higher concentration than tobacco smoke. Cellular, tissue, animal and human studies, and also epidemiological studies, show that marijuana smoke is a risk factor for lung cancer. Cannabis exposure doubles the risk of developing lung cancer. This should encourage clinicians to identify cannabis use and to offer patients support in quitting.
Copyright © 2014 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer bronchique; Cannabinoïdes; Cannabis; Lung cancer; Marijuana; Tetrahydrocannabinol; Tétrahydrocannabinol

Mesh:

Substances:

Year:  2014        PMID: 25012035     DOI: 10.1016/j.rmr.2013.12.002

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  3 in total

1.  Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals.

Authors:  R J Flanagan; J Lally; S Gee; R Lyon; S Every-Palmer
Journal:  Br Med Bull       Date:  2020-10-14       Impact factor: 4.291

2.  The Clinical Outcomes, Prognostic Factors and Nomogram Models for Primary Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Authors:  Li-Mei Luo; Ying Wang; Pei-Xian Lin; Chuang-Huang Su; Bao-Tian Huang
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

3.  Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.

Authors:  Zhe Zhao; Kailun Fei; Hua Bai; Zhijie Wang; Jianchun Duan; Jie Wang
Journal:  Thorac Cancer       Date:  2020-10-27       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.